MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Continuous subcutaneous foslevodopa/foscarbidopa: final results from a phase 3, open-label study

    J. Aldred, A. Amelin, A. Antonini, B. Bergmans, F. Bergquist, M. Bouchard, K. Budur, C. Carroll, K. Chaudhuri, S. Criswell, E. Danielsen, E. Freire Alvarez, F. Gandor, J. Jia, T. Kimber, H. Mochizuki, W. Robieson, A. Spiegel, D. Standaert, S. Talapala, M. Facheris, V. Fung (Spokane, USA)

    Objective: Evaluate safety and efficacy of foslevodopa/foscarbidopa (LDP/CDP) for patients with Parkinson’s disease (PD) in a 52-week, phase 3 study. Background: As PD progresses, patients…
  • 2023 International Congress

    Apathy in Parkinson’s disease: Relation to autonomic symptoms

    A. Ratajska, J. Goetz, L. Zahodne, C. Etheridge, D. Bowers (Gainesville, USA)

    Objective: Our overall goal was to learn whether apathy would be associated with autonomic symptoms in Parkinson’s disease (PD). We examined whether a) PD patients…
  • 2023 International Congress

    Low Vision Occupational Therapy for Parkinson’s Disease – A Pilot Study at the University of Alabama at Birmingham

    C. Parker, M. Maher, J. Vice, L. Lieb, M. Dean (BIRMINGHAM, USA)

    Objective: Assess usefulness of low vision occupational therapy (OT) in a small cohort of Parkinson’s disease (PD) patients. Background: PD patients report vision-related symptoms more…
  • 2023 International Congress

    Effect and Mechanism of Shaoyao Gancao Decoction(SGD) in Treatment of Pain in Parkinson’s Disease Based on Network Pharmacology and Molecular Docking

    Q. Zhao (Shanghai, China)

    Objective: Based on the method of network pharmacology, this paper discusses the potential effects and mechanisms of SGD in the treatment of pain in PD. Background:…
  • 2023 International Congress

    Online education to promote compensation strategies for gait impairments in underserved Parkinson populations

    T. Capato, A. Tosserams, B. Bloem, J. Nonnekes (São Paulo, Brazil)

    Objective: Here, we explore the potential health benefits of using an online educational platform about compensation strategies for gait impairment in Parkinson’s disease (PD), in…
  • 2023 International Congress

    Differences by sex in patients with Parkinson’s disease (PD) and impulse control disorder (ICD) in the Mexican population.

    A. Alcocer-Salas, M. Rodriguez-Violante, A. Cervantes-Arriaga, J. García-Hernández, A. Abundes-Corona, A. Hernández-Medrano, D. Aguila-Godinez, A. Herrera-Ruiz, E. Santiago-Delacruz, L. Lira-Juárez, M. Medrano-Delgado, M. Ruiz-Mafud, A. Regalado-Mustafá, D. Romero-Terán, M. Medina-Pérez, G. Hernandez-Armesto, A. Domínguez-García (Merida, Mexico)

    Objective: To identify motor, cognitive and overall ICDs differences by sex in Mexican patients with PD and ICDs Background: ICDs are characterized by a failure…
  • 2023 International Congress

    Neuropathic mechanism of paroxysmal kinesigenic dyskinesia based on EEG

    XJ. Huang, HC. Luo, TF. Yuan, L. Cao (Shanghai, China)

    Objective: To disclose the neural mechanism of paroxysmal kinesigenic dyskinesia (PKD) based on the findings from high-density electroencephalogram (hd-EEG) and to explore a neural biomarker for…
  • 2023 International Congress

    Basal ganglia shape in de novo Parkinson’s disease patients can predict the onset of Levodopa Induced Dyskinesias

    S. Shukla, M. Patnaik, A. Kumar, N. Thirugnanasambandam, S. Tinaz (Mumbai, India)

    Objective: In the current study, we aimed to examine structural MRI data from a large sample of de novo PD patients and to identify potential…
  • 2023 International Congress

    Is an integrated Parkinson’s Dementia Service the way forward?

    A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…
  • 2023 International Congress

    ParkProReakt Study Protocol – A randomized controlled trial to evaluate a proactive approach to health care in Parkinson’s disease

    M. van Munster, J. Stümpel, N. Altschuck, L. Kerkemeyer, I. Wellach, D. Becker, M. Geraedts, D. Pedrosa (Marburg, Germany)

    Objective: To implement and evaluate a novel care model for people with Parkinson’s Disease (PD), based on the following principles: proactive, person-centered, and digital (cf.…
  • « Previous Page
  • 1
  • …
  • 581
  • 582
  • 583
  • 584
  • 585
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley